AK-01 (LY3295668)

LY3295668 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AK-01 (LY3295668), covering 2021-07-02 to 2021-07-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of AK-01 (LY3295668) in Solid Tumors [Phase 1, Phase 2]